Omeros Corp. Stock
Price
Target price
€11.58
€11.58
-11.330%
-1.48
-11.330%
€31.01
06.01.26 / Frankfurt
WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omeros Corp. Stock
Omeros Corp. took a tumble today and lost -€1.480 (-11.330%).
Omeros Corp. is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
Based on the current price of 11.58 € the target price of 31 € shows a potential of 167.7% for Omeros Corp. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Omeros Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Non-cyclic/Cyclic" there were negative voices in the community.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | -11.330% | -14.222% | 25.528% | 15.800% | -14.222% | 345.042% | -6.575% |
| Ardelyx Inc. | 6.890% | 1.527% | -2.977% | -4.573% | 1.527% | 84.635% | -7.167% |
| Evolus Inc | 2.820% | -6.422% | -12.069% | -50.000% | -6.422% | -30.612% | 60.529% |
| Champions Oncology Inc | -0.900% | -5.172% | 8.911% | 15.546% | -5.172% | 37.500% | -38.547% |
Comments
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Ratings data for OMER provided by MarketBeat
Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Show more
Ratings data for OMER provided by MarketBeat
News
Why Omeros Stock Skyrocketed Today
For the most part, the stock market tends to be sedate in the late holiday season. That sure wasn't the case on Wednesday with Omeros (NASDAQ: OMER), which saw a nearly 76% share price leap after
Breakout Momentum Plays You Need to Know About
Momentum investors rely on a combination of astute analysis and timing to maximize gains. While this approach can carry a fair degree of risk, the allure of identifying a fast-growing stock and
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Shares of Omeros (NASDAQ: OMER) finished Oct. 14's trading session at $4.10 per share. When the market opened on Oct. 15, the stock was up by 181% at $11.52 per share.
It was a deal with the Danish